Drug Shortage Report for AMIODARONE HYDROCHLORIDE FOR INJECTION, USP
Report ID | 119581 |
Drug Identification Number | 02245248 |
Brand name | AMIODARONE HYDROCHLORIDE INJECTION |
Common or Proper name | Amiodarone Hydrochloride for Injection |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | AMIODARONE HYDROCHLORIDE |
Strength(s) | 50MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 50 mg/mL, MD Vial 3 mL |
ATC code | C01BD |
ATC description | ANTIARRHYTHMICS, CLASS I AND III |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2020-07-13 |
Actual start date | |
Estimated end date | 2020-08-21 |
Actual end date | 2020-08-05 |
Shortage status | Resolved |
Updated date | 2020-08-06 |
Company comments | Fresenius Kabi Canada Ltd. is pleased to advise that replenishment inventories of our Amiodarone Hydrochloride for Injection, 50 mg/mL, MD Vial 3 mL are now available at all distribution centres effective today, August 5, 2020. Please note that this product will remain on allocation. Contract customers will receive 100% of their historical monthly average volumes. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-07-06 | English | Compare |
v2 | 2020-07-06 | French | Compare |
v3 | 2020-07-14 | English | Compare |
v4 | 2020-08-05 | English | Compare |
v5 | 2020-08-05 | French | Compare |
v6 | 2020-08-06 | English | Compare |
Showing 1 to 6 of 6